Personalized chemo tested in major sarcoma trial
Disease control
Completed
This large, completed Phase 3 trial tested whether customizing chemotherapy based on a patient's specific sarcoma tumor type works better than a standard one-size-fits-all approach. It involved 550 adults with high-risk soft tissue sarcomas in their limbs or trunk wall. The main …
Phase: PHASE3 • Sponsor: Italian Sarcoma Group • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC